Status:
UNKNOWN
Vitamin D and Pre Cachexia and Cancer Cachexia in Epithelial Ovarian Cancer
Lead Sponsor:
Indonesia University
Collaborating Sponsors:
Dharmais National Cancer Center Hospital
Conditions:
Epithelial Ovarian Cancer
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
Several ex vivo, in vitro, and observational studies on various type of cancer shown positive effect of vitamin D. Vitamin D has widely known as immunomodulator property in various diseases. However, ...
Detailed Description
Studies result from laboratory suggested that vitamin D inhibit cancer cell proliferation and upregulate apoptosis pathway. Data from observational and ecology studies showed the inverse relationship ...
Eligibility Criteria
Inclusion
- age 18-60 years old who are newly diagnosed with ovarian cancer based on histopathology
- epithelial ovarian cancer stage II-III
- haven't received chemotherapy
- pre-cachexia or cachexia
- level of vitamin D below 30 ng/ml
- no vitamin D allergy
- ability and willingness to understand and provide informed consent
Exclusion
- autoimmune disease
- chronic liver disease
- chronic renal disease
- known had hypercalcemia
- refractory cachexia
Key Trial Info
Start Date :
January 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04864431
Start Date
January 12 2022
End Date
December 31 2023
Last Update
June 22 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Cipto Mangunkusumo Hospital
Jakarta, DKI Jakarta, Indonesia, 13430
2
Tarakan Hospital
Jakarta Pusat, Jakarta Special Capital Region, Indonesia, 13430
3
Dharmais National Cancer Hospital
Jakarta, Indonesia, 13430